Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lynx1 Capital Management LP Insider Profile
11 Followers
Lynx1 Capital Management LP, Ten Percent Owner at TScan Therapeutics, holds 9.26M shares in Passage Bio (Ticker: PASG), holds 5.36M shares in TScan Therapeutics (Ticker: TCRX). Most recently, Lynx1 Capital Management LP Bought ― shares of Passage Bio on Dec 31, 2024 for an estimated value of 239.13K.
Lynx1 Capital Management LP TScan Therapeutics (TCRX)Ten Percent Owner
TScan Therapeutics (TCRX)
Ten Percent Owner
Ranked #92,439 out of 100,285 Corporate Insiders
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-45.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lynx1 Capital Management LP holds in companies
Most Profitable Insider Trade
The most profitable trade made by Lynx1 Capital Management LP
Lynx1 Capital Management LP's Trading History
TScan Therapeutics
Dec 16, 2024
Ten Percent Owner
Informative Buy
385.40K
$12.86M
Passage Bio
Dec 31, 2024
Ten Percent Owner
Informative Buy
239.13K
$5.55M
List of latest transactions for each holding click on a transaction to see Lynx1 Capital Management LP's performance on stock
You May Also Like
Lynx1 Capital Management LP insider profile FAQ
What is the percentage of profitable transactions made by Lynx1 Capital Management LP?
The percentage of profitable transactions made by Lynx1 Capital Management LP is 40%.
What is the average return per transaction made by Lynx1 Capital Management LP?
The average return per transaction made by Lynx1 Capital Management LP is -45.50%.
What stocks does Lynx1 Capital Management LP hold?
Lynx1 Capital Management LP holds: TCRX, PASG stocks.
What was Lynx1 Capital Management LP’s latest transaction?
Lynx1 Capital Management LP latest transaction was an Informative Buy of $239.13K.
What was Lynx1 Capital Management LP's most profitable transaction?
Lynx1 Capital Management LP’s most profitable transaction was an Informative Buy of PASG stock on December 31, 2024. The return on the trade was 18.10%.
What is Lynx1 Capital Management LP's role in TScan Therapeutics?
Lynx1 Capital Management LP's role in TScan Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.